Telitacicept versus belimumab in proliferative lupus nephritis
Background and objectivesProliferative lupus nephritis (LN) is a severe pathological type of systemic lupus erythematosus with a high risk of progression to chronic kidney disease and end-stage renal disease. The prognosis of patients with proliferativ…